×
Download Brochure

Video Highlights

2024 Photos


Mark your calendar

Precision Med TRI-CON 2025
March 11-13, 2025
Town & Country Resort
San Diego, California

Precision Medicine Tri-Con 2024 Attracts More than 450 unique Organizations from 22 Different Countries

The 31st International Precision Med TRI-CON, held from March 26th to 28th, 2024, in San Diego, California, marked another successful convergence of leading minds in the field of precision medicine. With a robust program covering diverse topics such as AI in Precision Medicine, Diagnostics Market Access, Liquid Biopsy, and more, the conference provided a comprehensive platform for discussing the latest advancements and challenges in the industry. View More »


2024 Conference Programs



Register
Present a Poster - Posters Info
Sponsorship Opportunities
View Keynotes

TRI-CON 2024: Over 30 Years of Driving Innovation and Collaboration in Diagnostics and Precision Medicine

For 3 decades, the Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in implementing precision medicine, biomarkers and companion diagnostics, genomic medicine, and precision health; innovation and market access strategies for at-home diagnostics, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology, including multi-cancer early detection and minimal residual disease testing. Emerging implications of faster and cheaper sequencing, AI and digital tools, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024. Join us in sunny San Diego for the in-person networking and visionary and thought-provoking keynote discussions you’ve come to expect from the TRI-CON!



2024 Featured Speakers


J. Craig Venter

FIRESIDE CHAT: Artificial Intelligence Innovation for Precision Medicine

Eric Topol, MD, Director, Scripps Research Translational Institute; Executive Vice President and Professor, Scripps Research

Interviewed by: Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University


Kari Stefansson

Kari Stefansson
CEO
deCODE genetics

Mara Aspinall

Mara Aspinall
Partner
Illumina Ventures

Michael Pellini

Michael Pellini
General Partner
S32

Atul Butte

Atul Butte
Chief Data Scientist
University of California Health

Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health

Esther Babady

Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Jeffrey Venstrom

Jeffrey Venstrom
CMO
GRAIL

Razelle Kurzrock

Razelle Kurzrock
CMO
Worldwide Innovative Network for Personalized Cancer Therapy

Jonathan Carlson

Jonathan Carlson
Managing Director
Microsoft Health Futures

Sonya Makhni

Sonya Makhni
Medical Director
Mayo Clinic Platform

Ezra Cohen

Ezra Cohen
CMO, Oncology
Tempus Labs

Howard Scher

Howard Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center

Jean-Francois Martini

Jean-Francois Martini
Diagnostics Lead, Oncology
Pfizer

Justin Odegaard

Justin Odegaard
Vice President, Clinical Development
Guardant Health

Christopher Hartshorn

Christopher Hartshorn
Chief, Digital & Mobile Technologies
NCATS

Jai Pandey

Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi

Douglas Flora

Douglas Flora
Executive Medical Director, Oncology
St. Elizabeth’s Healthcare

Larissa May

Larissa May
Director, Emergency Medicine Innovation
UC Davis Health

Peter Bach

Peter Bach
CMO
Delfi Diagnostics

Anne Beaubrun

Anne Beaubrun
VP, Global Health Economics & Outcomes
Cepheid

Yuan Luo

Yuan Luo
Chief AI Officer, Northwestern Univ.
Feinberg School of Medicine

John Mattison

John Mattison
Chief Medical Information Officer
Arsenal Capital Partners

Jennifer Quigley

Jennifer Quigley
Sr. Director, Precision Diagnostics
Novartis

Scott Penberthy

Scott Penberthy
Managing Director, Applied AI
Google Cloud

Sudhir Srivastava

Sudhir Srivastava
Chief, Cancer Biomarkers Research
NCI

Edward Abrahams

Edward Abrahams
President
Personalized Medicine Coalition

Jonathan Beer

Jonathan Beer
Sr. Director, Diagnostic Science
Bristol Myers Squibb

Jim Almas

Jim Almas
VP, Clinical Effectiveness
LabCorp

Stacey DaCosta Byfield

Stacey DaCosta Byfield
VP, Genomic Health Economics and Outcomes
Optum Genomics

Anthony Sireci

Anthony Sireci
SVP, Diagnostics Development, Loxo Oncology
Eli Lilly

Noah Zimmerman

Noah Zimmerman
VP, Translational Science
Tempus

ankaj Vats

Pankaj Vats
Sr. Bioinformatics/Genomics Scientist
NVIDIA

Lesley Northrop

Lesley Northrop
Chief Diagnostic Officer
Everly Health

Charles Chiu

Charles Chiu
Director, Clinical Microbiology Laboratory
UCSF

Christopher Conn

Christopher Conn
Director, Diagnostics Strategy
Amgen

Key Contacts

For meeting questions or suggestions, please contact:

Julia Boguslavsky

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
juliab@healthtech.com

Partnering and Sponsorship
Opportunities

Companies A-K

Phillip Zakim-Yacouby

Phillip Zakim-Yacouby
Senior Business Development Manager
Cambridge Healthtech Institute
781-247-1815
pzakim-yacouby@cambridgeinnovationinstitute.com


Partnering and Sponsorship
Opportunities

Companies L-Z

Katelin Fitzgerald

Katelin Fitzgerald
Sr. Manager, Business Development
Cambridge Healthtech Institute
781-247-1824
kfitzgerald@cambridgeinnovationinstitute.com

For media and association partnerships, please contact:

Rich Handy

Rich Handy
Senior Director of Marketing
Cambridge Healthtech Institute
781-972-5456
rhandy@healthtech.com